A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2011
10/13/2011	US20110250277 Modified release compositions comprising tacrolimus
10/13/2011	US20110250267 Use of diindolylmethane-related indoles for the treatment and prevention of respiratory syncytial virus associated conditions
10/13/2011	US20110250265 Vaccine Preparation for Neospora Caninum Infection
10/13/2011	US20110250261 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription
10/13/2011	US20110250255 Drug coated stent with endosome-disrupting conjugate
10/13/2011	US20110250243 Nanoparticle compositions
10/13/2011	US20110250237 Immunogenic amphipathic peptide compositions
10/13/2011	US20110250235 Production of a saccharide composition comprising glucans and mannans by alkaline and acid hydrolysis of yeast cells
10/13/2011	US20110250234 Immunogenic Polypeptides Encoded by MAGE Minigenes and Uses Thereof
10/13/2011	US20110250233 Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase
10/13/2011	US20110250232 DNA-Transfection System for the Generation of Infectious Influenza Virus
10/13/2011	US20110250231 Method of using punicic acid to enhance immune response and prevent metabolic disorders
10/13/2011	US20110250229 Allogeneic cancer cell-based immunotherapy
10/13/2011	US20110250228 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin
10/13/2011	US20110250226 Composition containing extracts of fuscoporia obliqua, ganoderma lucidum and phellinus linteus for promoting the proliferation of hematopoietic stem cells
10/13/2011	US20110250225 Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
10/13/2011	US20110250224 Adjuvant combinations of liposomes and mycobacterial lipids for immunization compositions and vaccines
10/13/2011	US20110250223 Hybrid and tandem expression of neisserial proteins
10/13/2011	US20110250222 Antigenic polypeptides of chlamydia-related bacteria for diagnosis and vaccine
10/13/2011	US20110250221 Group A Streptococcus Pharmaceutical Compositions and Methods Thereof
10/13/2011	US20110250220 Modified gp140 envelope polypeptides of hiv-1 isolates, compositions, stabilized trimeric complexes, and uses thereof
10/13/2011	US20110250219 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
10/13/2011	US20110250218 Disease-Associated Antigens and Methods of Use Thereof
10/13/2011	US20110250217 Methods and compositions for eliciting an amyloid-selective immune response
10/13/2011	US20110250200 Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling
10/13/2011	US20110250196 Pharmaceutical composition using gonadotropin - releasing hormone (gnrh) combined variants as immunogen
10/13/2011	US20110250190 Pharmaceutical preparation
10/13/2011	US20110250175 Tlr7 ligand and uses thereof
10/13/2011	US20110250174 Stable immunogenic product comprising antigenic heterocomplexes
10/13/2011	US20110250173 Methods and compositions for inhibition of Treg cells
10/13/2011	US20110250172 Hepatitis c virus inhibitors
10/13/2011	US20110250168 Sialoadhesin-related compositions and methods
10/13/2011	US20110250167 Method for purifying proteins
10/13/2011	US20110250165 Antibodies against CXCR4 and Methods of Use Thereof
10/13/2011	US20110250134 Sustained release nitric oxide from long lived circulating nanoparticles
10/13/2011	US20110250130 Tnf-alpha binding proteins
10/13/2011	CA2795350A1 Ire-1.alpha. inhibitors
10/13/2011	CA2793940A1 Therapeutic use of the .beta.2m protein
10/12/2011	EP2374894A2 A method for producing influenza hemagglutinin multivalent vaccines
10/12/2011	EP2374883A1 Anti-cd4 antibody
10/12/2011	EP2374872A2 A method for the high level expression of active lymphotoxin-beta receptor immunoglobulin chimeric proteins and their purification
10/12/2011	EP2374871A1 Pluripotent stem cells, method for preparation thereof and uses thereof
10/12/2011	EP2374819A1 Antibodies to MASP-2
10/12/2011	EP2374470A1 Therapeutic use of the Beta2m protein
10/12/2011	EP2373653A1 Pyrrolopyrazinyl urea kinase inhibitors
10/12/2011	EP2373645A1 Isoindolinone and related analogs as sirtuin modulators
10/12/2011	EP2373330A2 Methods for diagnosing and treating autoimmune disorders
10/12/2011	EP2373304A1 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
10/12/2011	EP1919906B1 3, 5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
10/12/2011	EP1893191B1 Medicinal acidic cannabinoids
10/12/2011	EP1525884B1 Aqueous liquid preparations and light-stabilized aqueous liquid preparations
10/12/2011	EP1448995B9 Assay for screening candidate drugs for the treatment of inflammatory diseases
10/12/2011	EP1366022B1 Rgd-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects
10/12/2011	CN1981761B Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases
10/12/2011	CN1980638B Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids
10/12/2011	CN1849318B Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds
10/12/2011	CN102216318A Antioxidant
10/12/2011	CN102216299A 2, 5-diamino-substituted pyrido [4, 3-d] pyrimidines as autotaxin inhibitors against cancer
10/12/2011	CN102216265A Naphthylacetic acids
10/12/2011	CN102215873A Dendritic cell modulatory molecule
10/12/2011	CN102215867A Composition for treating disease
10/12/2011	CN102215855A Hypoallergenic dermatological composition
10/12/2011	CN102215841A Immunomodulating activities
10/12/2011	CN102215837A Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor
10/12/2011	CN102215836A Nutritional support to prevent or moderate bone marrow paralysis or neutropenia during anti-cancer treatment
10/12/2011	CN102212531A Preparation method and application of recombinant Cladosporium herbarum allergen Cla h8 protein
10/12/2011	CN102212447A Health-care wine
10/12/2011	CN102212446A Physical strength strengthening health-care medicinal liquor capable of tonifying kidney, strengthening yang and enhancing immunity and preparation method thereof
10/12/2011	CN102212008A Tanshinol ligustrazine derivative and preparation method and application thereof
10/12/2011	CN102210852A Treatment of T-cell mediated diseases
10/12/2011	CN102210849A Preparation of cyclosporine A nano-particle eye drop
10/12/2011	CN102210836A Application of Chinese medicinal composition in preparation of medicine for treating stomach cancer
10/12/2011	CN102210782A Compound traditional Chinese medicine for treating glucocorticoid dependence and application thereof
10/12/2011	CN102210741A Wall-breaking method for extraction of sophora flavescens
10/12/2011	CN102210726A Method for combined extraction of mallow flavones and mallow saponins in seashore mallow and application
10/12/2011	CN102210717A Compositions comprising Lactobacillus plantarum strains in combination with tannin and new Lactobacillus plantarum strains
10/12/2011	CN102210713A Traditional Chinese medicine for treating child measles
10/12/2011	CN102210700A Oral immunostimulation of mammals, birds, and reptiles from (1-4) linked beta-D-mannuronic acid
10/12/2011	CN102210680A Sinomenine derivatives for treating inflammatory disease by blocking macrophage p38 MAPK (mitogen activated protein kinase) signal transduction pathway
10/12/2011	CN102210666A Medical use of salvianolic acid A
10/12/2011	CN102210663A Diarylalkanes as potent inhibitors of binuclear enzymes
10/12/2011	CN102210639A Plant collagen essence
10/12/2011	CN101947213B Method for preparing microcapsules from peptidoglycan in lactic acid bacterial cell walls
10/12/2011	CN101869685B Health wine and preparation method thereof
10/12/2011	CN101586115B Gene coexpression recombinant plasmid and DNA vaccine prepared from same
10/12/2011	CN101411750B Oral Chinese medicine for treating chronic urticaria
10/12/2011	CN101195009B Powder medicament for treating scrotum eczema
10/11/2011	US8034958 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
10/11/2011	US8034933 graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides
10/11/2011	US8034908 Glycolipids and synthetic method thereof as well as their synthetic intermediates, and synthetic method thereof
10/11/2011	US8034826 Cycloalkane[B]azaindole antagonists of prostaglandin D2 receptors
10/11/2011	US8034818 Therapeutic uses of derivatives of piperidinyl- and piperazinyl-alkyl carbamates
10/11/2011	US8034615 Method for treating autoimmune diseases and screening method for preventive or therapeutic agent for the same
10/11/2011	US8034379 Hydrophilic gel foaming matrix; cellulose ethers
10/11/2011	US8034360 Use of human prostate cell lines in cancer treatment
10/11/2011	CA2494100C Pyrazole compositions useful as inhibitors of gsk-3
10/11/2011	CA2488934C Aryl oxime derivatives as phosphodiesterase iv inhibitors for the treatment of diseases
10/11/2011	CA2483620C Compositions for preventing or treating pollenosis, allergic nephritis, atopic dermatitis, asthma or urticaria
10/11/2011	CA2481561C Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity
10/11/2011	CA2476405C Compositions and methods for treatment of microbial infections

1 ... 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 ... 1172